What is the GLOW Stack?

The GLOW Stack is GHK-Cu (copper peptide) combined with BPC-157 and TB-500. It is designed for skin rejuvenation, collagen synthesis, and comprehensive tissue repair. GHK-Cu remodels the extracellular matrix and stimulates collagen production, BPC-157 promotes localized tissue repair and angiogenesis, and TB-500 provides systemic anti-inflammation and cell migration. Together, they address skin health, wound healing, and musculoskeletal recovery from three complementary angles.

How is the GLOW Stack different from the Wolverine Stack?

The Wolverine Stack (BPC-157 + TB-500) focuses purely on injury recovery and musculoskeletal healing. The GLOW Stack adds GHK-Cu, which introduces copper peptide-driven collagen synthesis, extracellular matrix remodeling, and potent antioxidant activity. This makes the GLOW Stack better suited for skin rejuvenation, anti-aging, wound healing, and scar reduction in addition to the standard tissue repair benefits of BPC-157 and TB-500.

Can I use topical GHK-Cu instead of injectable?

Topical GHK-Cu is effective for surface-level skin improvements such as fine lines, skin texture, and pigmentation. However, topical application does not achieve meaningful systemic levels. For joint, tendon, or deep tissue benefits, subcutaneous injection of GHK-Cu at 1–2 mg daily is recommended. Some users combine both: injectable GHK-Cu for systemic effects and a topical copper peptide serum for facial skin benefits.

Can I inject all three peptides in the same session?

Yes. GHK-Cu, BPC-157, and TB-500 can all be injected in the same session using separate syringes. Do not mix any of the three peptides in the same syringe, as stability and compatibility data for combined solutions is limited. Use a different injection site for each peptide or rotate within the same general area.

How long does the GLOW Stack take to show results?

Healing and anti-inflammatory effects from BPC-157 and TB-500 are often noticeable within 1–2 weeks. Skin improvements from GHK-Cu take longer because collagen remodeling is a slow biological process. Most users report visible skin texture and tone improvements at 4–6 weeks, with continued improvement through 8–12 weeks. Patience is essential — collagen turnover in the skin takes approximately 6–8 weeks.

Does GHK-Cu require a loading phase like TB-500?

No. GHK-Cu does not require a loading phase. It is dosed consistently at 1–2 mg subcutaneously once daily from day one. TB-500 is the only peptide in this stack that requires a loading phase (2–2.5 mg twice weekly for the first 4 weeks before dropping to once weekly maintenance).

Is the GLOW Stack safe?

All three peptides have demonstrated favorable safety profiles in animal studies and community use. GHK-Cu is a naturally occurring tripeptide found in human plasma and has been studied extensively by Loren Pickart and others since the 1970s. However, none of the three peptides is FDA-approved for human use, and controlled human clinical trial data is limited. Common side effects are mild: injection site irritation, occasional nausea, and transient fatigue. Consult a healthcare provider before use.

Will GHK-Cu turn my skin green or blue from the copper?

No. At the doses used in this stack (1–2 mg daily), GHK-Cu does not cause skin discoloration. The copper content in each dose is extremely small — far below levels that would cause visible color changes. Some users report a faint blue tint in the reconstituted solution, which is normal and reflects the copper content of the peptide. Injection site bruising is occasionally mistaken for copper-related discoloration.

Can I use the GLOW Stack for hair loss?

GHK-Cu has shown promise for supporting hair follicle health through its effects on extracellular matrix remodeling and growth factor signaling. Some users report improved hair thickness and reduced shedding when using GHK-Cu. However, this stack is primarily designed for skin and tissue repair. If hair loss is your primary concern, GHK-Cu alone or in combination with targeted hair-growth protocols may be more appropriate than the full GLOW Stack.

How many vials do I need for a full GLOW Stack cycle?

For an 8-week cycle: GHK-Cu at 2 mg daily requires 112 mg total (approximately eleven to twelve 10 mg vials). BPC-157 at 250 mcg twice daily requires 28 mg total (six 5 mg vials or three 10 mg vials). TB-500 at 2.5 mg twice weekly for 4 weeks (loading) then once weekly for 4 weeks (maintenance) requires 30 mg total (six 5 mg vials). The GLOW Stack is more peptide-intensive than the Wolverine Stack due to the addition of daily GHK-Cu.

Is the GLOW Stack banned in sports?

BPC-157 and TB-500 are both prohibited by the World Anti-Doping Agency (WADA) for competitive athletes. GHK-Cu is not currently explicitly listed on the WADA prohibited list, but athletes subject to anti-doping testing should avoid the entire stack due to the BPC-157 and TB-500 components.

Can I add GHK-Cu to an existing Wolverine Stack cycle?

Yes. If you are already running BPC-157 + TB-500, you can add GHK-Cu at 1–2 mg subcutaneously once daily at any point in the cycle. There is no need to restart the cycle. GHK-Cu works through different pathways (copper-dependent matrix remodeling) and does not interfere with BPC-157 or TB-500 mechanisms. Simply add it to your daily injection routine.

GHK-Cu + BPC-157 + TB-500 Stack Guide

The GLOW Stack — the ultimate tissue repair and skin rejuvenation combination. Complete dosing protocols, timing, cycling, and safety for GHK-Cu, BPC-157, and TB-500 together.

Compiled by PeptideWiki Editorial Team

Stack Overview

The GHK-Cu + BPC-157 + TB-500 combination — known as the “GLOW Stack” — is the most comprehensive peptide stack for skin rejuvenation, collagen synthesis, and tissue repair. It builds on the proven Wolverine Stack by adding GHK-Cu's copper peptide-driven extracellular matrix remodeling, collagen activation, and potent antioxidant activity to BPC-157's localized tissue repair and TB-500's systemic anti-inflammatory healing.

Key Characteristics:

3-peptide stack — GHK-Cu (copper tripeptide-1) + BPC-157 (Body Protection Compound-157) + TB-500 (Thymosin Beta-4 fragment)
Primary goal — skin rejuvenation, collagen synthesis, anti-aging, wound healing, joint and tendon repair, and comprehensive tissue recovery
Triple-mechanism synergy — GHK-Cu remodels the extracellular matrix and activates collagen; BPC-157 promotes local angiogenesis and growth factors; TB-500 drives systemic anti-inflammation and cell migration
Experience level — intermediate; recommended for users with prior peptide experience due to the 3-compound protocol and daily injection commitment
Typical cycle — 6–8 weeks with TB-500 loading phase in the first 4 weeks
Administration — subcutaneous injection for all three peptides; GHK-Cu can also be applied topically for surface skin benefits; BPC-157 can be taken orally for gut conditions

Use our Peptide Dosage Calculator to calculate exact doses for all three peptides based on your vial sizes and reconstitution volumes.

Important: GHK-Cu, BPC-157, and TB-500 are not FDA-approved for human use. All three are classified as research peptides. All dosing information in this guide is derived from animal studies and community protocols — not from human clinical trials. Consult a healthcare provider before using any research peptide.

Why This Stack Works

The GLOW Stack is effective because it combines three peptides that operate through fundamentally different but complementary mechanisms. Rather than addressing a single pathway, this combination targets tissue repair from three distinct angles: matrix remodeling, localized repair, and systemic healing.

GHK-Cu: The Matrix Remodeler

Collagen synthesis: directly stimulates production of collagen types I, III, and V in fibroblasts, rebuilding the structural foundation of skin, tendons, and connective tissue
Extracellular matrix remodeling: activates matrix metalloproteinases (MMPs) that break down damaged tissue while simultaneously promoting deposition of new, organized matrix components
Antioxidant and anti-inflammatory: one of the most potent natural antioxidants, neutralizing free radicals and reducing oxidative damage that accelerates tissue aging
Immune cell attraction: attracts macrophages and mast cells to sites of damage, coordinating the immune response for efficient wound healing and tissue remodeling

BPC-157: The Local Repair Agent

Angiogenesis: upregulates VEGF (vascular endothelial growth factor), promoting formation of new blood vessels at the injury site to deliver nutrients and oxygen
Growth factor expression: increases EGF, FGF, and other factors that stimulate cell proliferation and tissue remodeling
Nitric oxide modulation: interacts with the NO system to regulate blood flow, inflammation, and repair signaling at the injury site
Tendon and collagen: enhances tendon-to-bone healing and collagen organization in animal models

TB-500: The Systemic Healer

Actin regulation: sequesters G-actin to promote cell migration, allowing repair cells to reach damaged tissue faster
Anti-inflammatory: reduces systemic inflammation, creating a more favorable environment for healing throughout the body
Flexibility and remodeling: promotes tissue remodeling and reduces scar tissue formation, improving functional recovery
Blood cell production: stimulates new blood cell formation and improves endothelial cell function

The Triple Synergy

GHK-Cu rebuilds the structural framework — collagen matrix, connective tissue scaffolding, and skin architecture. BPC-157 creates a favorable local healing environment with new blood vessels, growth factors, and enhanced nitric oxide signaling. TB-500 reduces systemic inflammation and promotes the migration of repair cells toward these enriched environments. The result is faster, more complete tissue repair with visible skin improvements that neither the Wolverine Stack nor GHK-Cu alone can match.

Evidence note: GHK-Cu has been studied extensively since the 1970s by Loren Pickart and others, with strong evidence for collagen synthesis and wound healing in vitro and in animal models. BPC-157 and TB-500 also have extensive animal research. The synergistic benefit of combining all three is primarily supported by community experience and mechanistic reasoning rather than controlled human trials of the specific combination.

Individual Peptide Breakdown

Each peptide in this stack has a dedicated dosage guide with complete individual protocols. Here is a summary of each peptide's role in the GLOW Stack.

GHK-Cu (Copper Tripeptide-1)

Type: Naturally occurring copper-binding tripeptide (3 amino acids + Cu2+)
Origin: Found naturally in human plasma, saliva, and urine; levels decline with age
Role in stack: Collagen synthesis, extracellular matrix remodeling, antioxidant protection, immune cell recruitment
Route: Subcutaneous injection or topical
Frequency: Once daily

Full GHK-Cu Dosage Guide →

BPC-157 (Body Protection Compound-157)

Type: Synthetic pentadecapeptide (15 amino acids)
Origin: Derived from human gastric juice proteins
Role in stack: Localized tissue repair, angiogenesis, growth factor upregulation
Route: Subcutaneous injection (near injury) or oral
Frequency: Once or twice daily

Full BPC-157 Dosage Guide →

TB-500 (Thymosin Beta-4 Fragment)

Type: Synthetic peptide fragment of Thymosin Beta-4 (43 amino acids)
Origin: Based on naturally occurring thymic peptide involved in cell migration
Role in stack: Systemic anti-inflammation, cell migration, tissue remodeling
Route: Subcutaneous injection
Frequency: Twice weekly (loading), once weekly (maintenance)

Full TB-500 Dosage Guide →

Dosing Protocol

The GLOW Stack uses different dosing frequencies for each peptide. GHK-Cu and BPC-157 are injected daily, while TB-500 follows a loading/maintenance schedule with less frequent injections.

Standard Protocol

Compound	Dose	Frequency	Route	Notes
GHK-Cu	1–2 mg	Once daily	SubQ (abdomen or target area)	Consistent daily dosing throughout the entire cycle; start at 1 mg and increase to 2 mg if well tolerated
BPC-157	250 mcg	Once or twice daily	SubQ (near injury or target area)	Consistent daily dosing throughout the entire cycle
TB-500	2–2.5 mg	Twice weekly (loading)	SubQ (abdomen or near injury)	Loading phase: weeks 1–4 to build systemic levels
TB-500	2–2.5 mg	Once weekly (maintenance)	SubQ (abdomen or near injury)	Maintenance phase: weeks 5–8 after loading

Skin-Focused Protocol (Lower Dose)

Compound	Dose	Frequency	Route	Notes
GHK-Cu	1 mg	Once daily	SubQ + optional topical	Add a copper peptide serum for facial skin if desired
BPC-157	250 mcg	Once daily	SubQ	Suitable for skin focus without acute injury
TB-500	2 mg	Twice weekly	SubQ	4-week loading, then once weekly maintenance

Protocol selection: The standard protocol is recommended for users with active injuries, joint issues, or significant skin damage. The skin-focused protocol is appropriate for anti-aging and general skin rejuvenation without acute tissue damage, or for users new to multi-peptide stacks who want to assess tolerance before increasing doses.

Calculate Your Doses

All three peptides are supplied as lyophilized powder and need reconstitution with bacteriostatic water. The dose you draw depends on the concentration after reconstitution.

GHK-Cu — 10 mg Vial

Vial size: 10 mg (10,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 10,000 ÷ 2 = 5,000 mcg/mL (5 mg/mL)
2 mg dose = 0.4 mL = 40 units on insulin syringe
Doses per vial: 5 doses (at 2 mg)

BPC-157 — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 5,000 ÷ 2 = 2,500 mcg/mL
250 mcg dose = 0.1 mL = 10 units on insulin syringe
Doses per vial: 20 doses

TB-500 — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 1 mL
Concentration: 5,000 ÷ 1 = 5,000 mcg/mL
2.5 mg dose = 0.5 mL = 50 units on insulin syringe
Doses per vial: 2 doses

Skip the Math — Use Our Calculator

Enter your vial size, water volume, and desired dose for each peptide — get instant calculations with zero manual math.

Reconstitution Guide

All three peptides follow the same reconstitution process. Reconstitute each vial separately with bacteriostatic water.

Peptide	Vial Size	Bac Water	Concentration	Standard Dose Draw
GHK-Cu	10 mg	2 mL	5 mg/mL	40 units (0.4 mL) for 2 mg
BPC-157	5 mg	2 mL	2,500 mcg/mL	10 units (0.1 mL) for 250 mcg
TB-500	5 mg	1 mL	5,000 mcg/mL	50 units (0.5 mL) for 2.5 mg

Wash Hands & Prepare Workspace

Wash hands thoroughly. Lay out supplies: peptide vials, bacteriostatic water, insulin syringes, and alcohol swabs on a clean surface.

Swab All Vial Stoppers

Remove plastic caps and swab the rubber stoppers of each peptide vial and the bacteriostatic water vial with alcohol pads. Let air-dry for 10–15 seconds.

Add Water to Each Peptide Vial

Draw the appropriate volume of bacteriostatic water for each vial. Insert needle and direct the stream down the inside glass wall — never squirt directly onto the powder. Release slowly. Reconstitute each vial separately.

Dissolve Gently

Let each vial sit for 1–2 minutes, then gently swirl or roll between palms until fully dissolved. GHK-Cu solution may have a faint blue tint from the copper — this is normal. All solutions should be clear. Never shake.

Label & Refrigerate

Write the reconstitution date and concentration on each vial. Store all vials refrigerated at 2–8°C. Use within 28–30 days.

For a detailed visual walkthrough, see our Reconstitution Guide.

Timing & Daily Schedule

The three peptides in this stack have different dosing frequencies. Here is how a typical week looks during the loading phase (weeks 1–4):

Day	GHK-Cu	BPC-157	TB-500
Monday	2 mg	250 mcg AM + 250 mcg PM	2.5 mg
Tuesday	2 mg	250 mcg AM + 250 mcg PM	—
Wednesday	2 mg	250 mcg AM + 250 mcg PM	—
Thursday	2 mg	250 mcg AM + 250 mcg PM	2.5 mg
Friday	2 mg	250 mcg AM + 250 mcg PM	—
Saturday	2 mg	250 mcg AM + 250 mcg PM	—
Sunday	2 mg	250 mcg AM + 250 mcg PM	—

Timing Notes

GHK-Cu: Once daily at a consistent time. Morning is most common. No strict meal or fasting requirements.
BPC-157: Split doses 8–12 hours apart (e.g., 8 AM and 8 PM) when dosing twice daily. No strict meal or fasting requirements for injectable dosing.
TB-500: Can be injected at any time of day. Space injections 3–4 days apart during loading (e.g., Monday/Thursday or Tuesday/Friday).
Same session: All three peptides can be injected in the same session using separate syringes. No waiting period between injections.
Injection sites: GHK-Cu in the abdomen or near the target area; BPC-157 near the injury or target tissue for localized effect; TB-500 works systemically from any SubQ site (abdomen is most convenient).

Maintenance phase (weeks 5–8): GHK-Cu and BPC-157 continue daily as before. TB-500 drops to once weekly — pick one consistent day (e.g., every Monday).

Cycling & Duration

The GLOW Stack is typically run for 6–8 weeks. Longer cycles are possible for chronic skin conditions or deep tissue damage but should include periodic reassessment.

Phase	Duration	GHK-Cu	BPC-157	TB-500
Loading	Weeks 1–4	1–2 mg daily	250 mcg 1–2x/day	2–2.5 mg 2x/week
Maintenance	Weeks 5–8	1–2 mg daily	250 mcg 1–2x/day	2–2.5 mg 1x/week
Break	2–4 weeks off	None	None	None
Repeat (if needed)	6–8 weeks	Resume daily	Resume daily	Resume with loading phase

When to Extend the Cycle

Significant skin damage or scarring: Deep scars, sun damage, or post-surgical skin may need 10–12 weeks for meaningful collagen remodeling
Chronic tendinopathy with skin concerns: When addressing both internal tissue repair and external skin health simultaneously
Anti-aging protocols: Some users run GHK-Cu alone at maintenance doses after completing the full GLOW Stack cycle for ongoing collagen support

Why Take a Break?

The break period serves to: (1) assess improvements without peptide support and confirm that collagen remodeling is structural, (2) allow the body to consolidate the tissue changes stimulated during the cycle, and (3) reduce unnecessary exposure to research compounds when the therapeutic goal may have been achieved. GHK-Cu in particular stimulates long-lasting matrix changes that continue developing after the peptide is discontinued.

Safety, Side Effects & Contraindications

Safety profile: All three peptides in the GLOW Stack have demonstrated favorable safety profiles in animal studies and community use. GHK-Cu is a naturally occurring human peptide with decades of research by Loren Pickart and others. However, human clinical trial data for all three peptides (especially in combination) is limited, and long-term safety has not been formally evaluated.

Common Side Effects

Injection site redness, soreness, or minor swelling — the most common report across all three peptides
GHK-Cu injection site may show mild irritation or warmth due to the copper component
Mild nausea — more common with BPC-157, usually resolves within days
Transient fatigue or lethargy — occasionally reported
Headache — may occur in the first few days of use
Faint blue tint at injection site — rare, related to copper in GHK-Cu, resolves quickly

Contraindications

Active cancer or history of cancer: All three peptides promote aspects of tissue growth — BPC-157 promotes angiogenesis, TB-500 drives cell migration, and GHK-Cu stimulates cell proliferation. These effects could theoretically support tumor growth. Avoid use with active malignancies.
Wilson's disease or copper metabolism disorders: GHK-Cu introduces additional copper into the body. Individuals with Wilson's disease or other copper accumulation disorders should not use GHK-Cu.
Pregnancy and breastfeeding: No safety data exists for any of these peptides during pregnancy or nursing. Avoid entirely.
Active infections at injection site: Do not inject through infected, inflamed, or broken skin.
Anticoagulant therapy: BPC-157 interacts with the NO system and may affect platelet function. Consult your healthcare provider if taking blood thinners.

Stack-Specific Safety Notes

No known negative interaction: GHK-Cu, BPC-157, and TB-500 have not been shown to interfere with each other. They operate through different mechanisms and pathways.
Increased angiogenic and proliferative load: The three-peptide combination promotes tissue growth through multiple pathways simultaneously. While beneficial for repair, this reinforces the theoretical concern about use with active cancers.
Copper accumulation: At recommended doses (1–2 mg/day), GHK-Cu contributes a very small amount of copper. This is not a concern for healthy individuals, but those on copper-containing supplements should be aware of cumulative intake.
Separate syringes: Use dedicated syringes for each peptide. The copper ion in GHK-Cu could potentially interact with other peptides if mixed in solution.

Regulatory status: GHK-Cu, BPC-157, and TB-500 are not FDA-approved for human use. All three are classified as research peptides. BPC-157 and TB-500 are prohibited by WADA for competitive athletes. Regulations vary by jurisdiction — verify your local laws before purchasing.

Common GLOW Stack Mistakes

Avoid these common errors to get the most out of your GHK-Cu + BPC-157 + TB-500 protocol:

Using topical GHK-Cu and expecting systemic effects

Topical copper peptide serums improve surface skin quality but do not penetrate deeply enough for joint, tendon, or systemic tissue repair. For deep tissue and systemic benefits, subcutaneous injection at 1–2 mg daily is required.

Skipping the TB-500 loading phase

TB-500 requires a loading phase (2–2.5 mg twice weekly for 4 weeks) to build up systemic levels. Starting at the maintenance dose provides inadequate initial tissue saturation and delays results significantly.

Expecting visible skin results in the first week

Collagen synthesis and extracellular matrix remodeling are slow biological processes. GHK-Cu stimulates these pathways, but visible skin improvements typically require 4–6 weeks of consistent use. Healing peptide effects (BPC-157 and TB-500) appear faster, but skin rejuvenation requires patience.

Applying topical GHK-Cu on broken or actively inflamed skin

Copper peptide applied to open wounds, active acne lesions, or freshly treated skin (post-laser, post-peel) can cause irritation and worsen inflammation. Allow wounds to close and acute inflammation to subside before applying topical GHK-Cu. Injectable GHK-Cu does not have this limitation.

Mixing all three peptides in the same syringe

Stability and compatibility data for combining GHK-Cu, BPC-157, and TB-500 in a single syringe is not established. The copper ion in GHK-Cu could potentially interact with other peptides in solution. Use separate syringes for each peptide.

Using the same reconstitution volume for all three peptides

GHK-Cu, BPC-157, and TB-500 have different dose sizes and vial concentrations. Calculate reconstitution volumes independently for each peptide to ensure accurate dosing. Using the dosage calculator prevents errors.

Not refrigerating reconstituted vials

All three peptides must be refrigerated at 2–8°C after reconstitution. GHK-Cu in particular is sensitive to degradation at room temperature. Use reconstituted vials within 28–30 days.

Taking excessive GHK-Cu doses for faster results

GHK-Cu follows a dose-response curve where higher is not necessarily better. Doses above 2–3 mg daily have not been shown to provide additional benefit in community reports and may increase injection site irritation. Stick to the 1–2 mg daily range.

Frequently Asked Questions

Key Takeaways

The GLOW Stack (GHK-Cu + BPC-157 + TB-500) is the most comprehensive skin and tissue repair peptide combination — addressing tissue recovery through matrix remodeling (GHK-Cu), localized repair (BPC-157), and systemic healing (TB-500)
GHK-Cu dose: 1–2 mg SubQ once daily throughout the entire 6–8 week cycle for collagen synthesis and matrix remodeling
BPC-157 dose: 250 mcg SubQ once or twice daily near the injury or target area throughout the cycle
TB-500 dose: 2–2.5 mg SubQ twice weekly (loading) then once weekly (maintenance)
TB-500 requires a loading phase (weeks 1–4) to build systemic levels before dropping to maintenance
Use separate syringes for each peptide — do not mix any of the three in the same syringe
Be patient with skin results — collagen remodeling takes 4–6 weeks to become visible, with continued improvement through 8–12 weeks
Typical cycle: 6–8 weeks with 2–4 weeks off before repeating if needed
Refrigerate all reconstituted vials at 2–8°C and use within 28–30 days
Avoid with active cancer or copper metabolism disorders — all three peptides promote tissue growth pathways
None of these peptides is FDA-approved for human use. All are classified as research peptides. BPC-157 and TB-500 are banned by WADA.

This article is for educational and informational purposes only. GHK-Cu, BPC-157, and TB-500 are not approved by the FDA for human use and are classified as research peptides. They are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before using any research peptide, especially if you have pre-existing medical conditions, are taking medications, or are pregnant or nursing. See our Medical Disclaimer.

References

Pickart L, Margolina A. “Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.” Int J Mol Sci. 2018;19(7):1987.
Pickart L. “The human tri-peptide GHK and tissue remodeling.” J Biomater Sci Polym Ed. 2008;19(8):969-988.
Canapp SO Jr, et al. “The effect of topical tripeptide-copper complex on healing of ischemic open wounds.” Vet Surg. 2003;32(6):515-523.
Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.” Curr Pharm Des. 2018;24(18):1990-2001.
Staresinic M, et al. “Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon.” J Orthop Res. 2003;21(6):976-983.
Goldstein AL, et al. “Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues.” Trends Mol Med. 2005;11(9):421-429.
Malinda KM, et al. “Thymosin beta4 accelerates wound healing.” J Invest Dermatol. 1999;113(3):364-368.
Pickart L, et al. “GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.” Biomed Res Int. 2015;2015:648108.
Seiwerth S, et al. “BPC 157's effect on healing.” J Physiol Paris. 2014;108(2-3):51-59.

Next Steps

Continue your research with these resources.

GHK-Cu Dosage Guide

Complete individual dosing protocols, reconstitution, and injection guide for GHK-Cu copper peptide.

Read Guide

BPC-157 Dosage Guide

Complete individual dosing protocols, reconstitution, and injection guide for BPC-157.

Read Guide

TB-500 Dosage Guide

Complete individual dosing protocols, loading/maintenance phases, and safety for TB-500.

Read Guide

Wolverine Stack Guide

The simpler BPC-157 + TB-500 healing stack if you want tissue repair without the skin rejuvenation focus.

Read Guide

Dosage Calculator

Calculate exact doses for all three peptides based on vial size and reconstitution volume.

Open Calculator